Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells

Scandinavian Journal of Immunology

Volumn 49, Issue 2, 1999, Pages 184-192

  King, D E ^a   Jiang, H ^a   Simkin, G O ^a   Obochi, M O K ^a   Levy, J G ^a,b   Hunt, David W C ^a,b  

^a QLT PhotoTherapeutics Inc   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BENZOPORPHYRIN DERIVATIVE; CD11B ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CELL MARKER; CELL SURFACE RECEPTOR; FAS ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; ULTRAVIOLET B RADIATION;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; LIGHT; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RECEPTORS, CELL SURFACE; SPLEEN; ULTRAVIOLET RAYS;

EID: 0033049356     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00498.x     Document Type: Article

References (64)

1. Levy JG. Photodynamic therapy, Trends Biotechnol 1995;13:14-8.
2. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-57.
3. Doughery TJ, Gomer CJ, Henderson Jori G et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
4. Elmets CA, Bowen KD. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. Cancer Res 1986;46:1608-11.
5. Musser DA, Fiel RJ. Cutaneous photosensitising and immuno-suppressive effects of a series of turnout localizing porphyrins. Photochem Photobiol 1991;53:119-23.
6. Simkin GO, King DE, Levy JG, Chan AH, Hunt DWC. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative. Immunopharmacology 1997;37:221-30.
7. Chowdhary RK, Ratkay LG, Neyndorff HC et al. The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice. Clin Immunol Immunopathol 1994;72:255-63.
8. Ratkay LG, Chowdhary RK, Neyndorff HC, Tonzetich J, Waterfield JD, Levy JG. Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice. Clin Exp Immunol 1994;95:373-7.
9. Leong S, Chan AH, Levy JG, Hunt DWC. Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis. Photochem Photobiol 1996;64:751-7.
10. Obochi MOK, Canaan AJ, Jain AK, Richter AM, Levy JG. Targeting activated lymphocytes with photodynamic therapy: susceptibility of mitogen-stimulated splenic lymphocytes to benzoporphyrin derivative (BPD) photosensitization. Photochem Photobiol 1995;62:169-75.
11. Gruner S, Meffert H, Volk D, Grunow R, Jahn S. The influence of haematoporphyrin derivative and visible light on murine skin graft survival, epidermal Langerhans' cells and stimulation of the allogeneic mixed leukocyte reaction. Scand J Immunol 1985;21:267-73.
12. Obochi MOK, Ratkay LG, Levy JG. Prolonged skin allograft survival after photodynamic therapy (PDT) associated with modification of donor skin antigenicity. Transplantation 1997;63:810-7.
13. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992;10:333-58.
14. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
15. Crowley MT, Inaba K, Witmer-Pack MD, Gezelter S, Steinman RM. Use of the fluorescence-activated cell sorter to enrich dendritic cells from mouse spleen. J Immunol Methods 1990;133:55-66.
16. Inaba K, Witmer-Pack M, Inaba M et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994;180:1849-60.
17. Swiggard WJ, Nonacs RM, Witmer-Pack MD, Steinman RM. Enrichment of dendritic cells by plastic adherence and EA rosetting. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Immunology, 2nd edn. Brooklyn, NY: Greene Publishing Associates and Wiley Interscience, 1991:3.7.1-3.7.11.
18. Coffman R. Surface antigen expression and immunoglobulin rearrangement during mouse pre-B cell development. Immunol Rev 1982;69:5-23.
19. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone J. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 1987;84:1374-8.
20. Ledbetter JA, Rouse RV, Micklem HS, Herzenberger LA. T cell subsets defined by expression of Lyt-1, 2, 3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med 1980;152:280-95.
21. Hunt DWC, Sorrenti RA, Smits CB, Levy JG. Photofrin® but not benzoporphyrin derivative stimulates hematopoiesis in the mouse. Immunopharmacology 1993;26:203-12.
22. Dai R, van Rooijen N, Dijkstra CD, Streilen JW. Relative roles of T cells and macrophages in cytokine-mediated functional transformation of cultured splenic dendritic cells. Cell Immunol 1995;162:265-74.
23. Springer TA, Davignon D, Ho MK, Kurzinger K, Martz E, Sanchez-Madrid F. LFA-1 and Lyt-2,3 molecules associated with T lymphocyte-mediated killing; and Mac-1, an LFA-1 homologue with complement receptor function. Immunol Rev 1982;68:171-95.
24. Springer T, Galfre G, Secher DS, Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 1979;9:301-6.
25. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med 1990;171:1753-71.
26. Trowbridge IS, Omary MB. Molecular complexity of leukocyte surface glycoproteins related to the macrophage differentiation antigen Mac-1. J Exp Med 1981;154:1517-24.
27. Ortega GO, Robb RJ, Shevach EM, Malek TR. The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells. J Immunol 1984;133:1970-75.
28. Ledbetter JA, Herzenberg LA. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979;47:63-90.
29. Scheynius A, Camp RL, Pure E. Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J Immunol 1993;150:655-63.
30. Razi-Wolf Z, Freeman GJ, Galvin F, Beraceraf B, Nadler L, Reiser H. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc Natl Acad Sci USA 1992;89:4210-4.
31. Hathcock K, Laszlo G, Dickler H, Bradshaw J, Linsley P, Hodes R. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 1993;262:905-7.
32. Ogasawara J, Watanabe-Fukunaga R, Adachi M et al. Lethal effects of the anti-Fas antibody in mice, Nature 1993;364:806-9.
33. d antigens on the surface of these cells. Transplantation 1982;34:113-20.
34. Kraal G, Breel M, Janse M, Bruin G. Langerhans' cells, veiled cells and interdigitating cells in the mouse recognized by a monoclonal antibody. J Exp Med 1986;163:981-97.
35. Jiang W, Swiggard WJ, Heufler C et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995;375:151-5.
36. Granville DJ, Levy JG, Hunt DWC. Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death and Different 1997;4:623-8.
37. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide and flow cytometry. J Immunol Methods 1991;139:271-16.
38. Springer TA. Adhesion molecules of the immune system. Nature 1990;346:425-34.
39. Hathcock KS, Hirano H, Murakami S, Hodes RJ. CD45 expression by B cells. Expression of different CD45 isoforms by subpopulations of activated B cells. J Immunol 1992;49:2286-94.
40. Hunt DWC, Jiang H, Granville DJ, Chan AH, Leong S, Levy JG. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology; in press.
41. Granville DJ, Carthy CM, Jiang H, Shore GC, McManus BM, Hunt DWC. Rapid cytochrome c release, activation of caspases 3,6,7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy. FEBS Lett 1998;437:5-10.
42. Tang A, Udey MC. Inhibition of epidermal Langerhans' cell function by low dose ultraviolet B radiation: ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans' cells. J Immunol 1991;146:3347-55.
43. Weiss JM, Renkl AC, Denfeld RW et al. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans' cells. Eur J Immunol 1995;25:2858-62.
44. Young JW, Baggers J, Soergel SA. High-dose UV-B radiation alters human dendritic cell co-stimulatory activity but does not allow dendritic cells to tolerize T lymphocytes to alloantigen in vitro. Blood 1993;81:2987-97.
45. Pamphilon DH, Alnaqdy AA, Wallington TB. Immunomodulation by ultraviolet light: clinical studies and biological effects. Immunol Today 1991;12:119-23.
46. Schuler G, Steinman RM. Murine epidermal Langerhans' cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985;161:526-46.
47. Bacci S, Nakamura T, Streilin JW. Failed antigen presentation after UVB radiation correlates with modifications of Langerhans' cell cytoskeleton. J Invest Dermatol 1996;107:838-43.
48. Krutman J, Athar M, Mendel DB et al. Inhibition of the high affinity Fc receptor (FcgRI) on human monocytes by porphyrin photosensitization is highly specific and mediated by the generation of superoxide radicals. J Biol Chem 1989;264:11407-13.
49. Gruner S, Volk H, Noack F, Meffert H, Von Baehr R. Inhibition of HLA-DR antigen expression and of the mixed leukocyte reaction by photochemical treatment. Tissue Antigens 1986;27:147-54.
50. Girotti AW. Photodynamic lipid peroxidation in biological systems. Photochem Photobiol 1990;51:497-509.
51. Pure E, Inaba K, Crowley MT et al. Antigen processing by epidermal Langerhans' cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J Exp Med 1990;172:1459-69.
52. Kämpgen E, Koch E, Koch F et al. Class II histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci USA 1991;88:3104-018.
53. de Davies CL, Ranheim T, Malik Z, Rofstad EK, Moan J, Lindmo T. Relationship between changes in antigen expression and protein synthesis in human melanoma cells after hyperthermia and photodynamic therapy. Br J Cancer 1988;58:307-13.
54. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
55. Koppi TA, Tough-Bement T, Lewinsohn DM, Lynch DH, Alderson MR. CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells. Eur J Immunol 1997;27:3161-5.
56. Koch F, Stanzl U, Jennewein P et al. High level IL-12 production by murine dendritic cells: down-regulation via MHC Class II and CD40 molecules and down-regulation by IL-4 and IL-10. J Exp Med 1996;184:741-6.
57. Caux C, Massacrier C, Vanbervliet B et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994;180:1263-72.
58. Macatonia SE, Hosken NA, Litton M et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995;154:5071-9.
59. Wu L, Li C-L, Shortman K. Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J Exp Med 1996;184:903-11.
60. Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs. Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol 1997;159:565-73.
61. Suss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 1996;183:1789-96.
62. Tsai V, Zvaifler NJ. Dendritic cell-lymphocyte clusters that form spontaneously in rheumatoid arthritis synovial effusions differ from clusters formed in human mixed leukocyte reactions. J Clin Invest 1988;82:1731-45.
63. Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994;152:2613-23.
64. Thomas R, Lipsky PE. Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis? Immunol Today 1996;1:559-64.